CWF19L1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.22044604925031E-16 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.35950140034424E-11 |
Normal-vs-Stage2 |
1.028450E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.475800E-03 |
Stage1-vs-Stage2 |
3.735000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.218140E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.520400E-02 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.93729534823251E-14 |
Normal-vs-AfricanAmerican |
2.427000E-01 |
Normal-vs-Asian |
1.862290E-02 |
Caucasian-vs-AfricanAmerican |
7.048200E-01 |
Caucasian-vs-Asian |
7.626200E-01 |
AfricanAmerican-vs-Asian |
5.623400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.22969995192324E-09 |
Normal-vs-Female |
1.20219999510951E-08 |
Male-vs-Female |
9.091200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.1846000000012E-05 |
Normal-vs-Extreme_Weight |
1.31610000009275E-07 |
Normal-vs-Obese |
4.375000E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.859400E-01 |
Normal_Weight-vs-Obese |
1.065760E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.063630E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.768800E-01 |
Normal-vs-Age(41-60Yrs) |
1.75319999629053E-08 |
Normal-vs-Age(61-80Yrs) |
4.0294999559265E-09 |
Normal-vs-Age(81-100Yrs) |
1.756980E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.731400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.294600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.154000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.450390E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.819400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.917800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.631000E-01 |
Normal-vs-Grade 3 |
6.357600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.327600E-01 |
Grade 2-vs-Grade 4 |
7.631000E-01 |
Grade 3-vs-Grade 4 |
6.357600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.43773881688958E-13 |
Normal-vs-N1 |
2.832100E-02 |
N0-vs-N1 |
1.115570E-02 |
|
|